Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker IBIO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | Marc Banjak Chief Legal Officer | IBIO iBio, Inc. | Buy | 1,434 | $1.76 | $2,524 Buy | Form 4 ↗ |
| Mar 26, 2026 | Marc Banjak Chief Legal Officer | IBIO iBio, Inc. | Buy | 12,500 | $1.64 | $20.5K Buy | Form 4 ↗ |
| Mar 19, 2026 | Felipe Duran Chief Financial Officer | IBIO iBio, Inc. | Buy | 24,835 | $2.02 | $50.2K Buy | Form 4 ↗ |
| Mar 19, 2026 | Martin Brenner See Remarks, Director | IBIO iBio, Inc. | Buy | 12,336 | $2.02 | $24.9K Buy | Form 4 ↗ |
| Jan 10, 2025 | Felipe Duran Chief Financial Officer | IBIO iBio, Inc. | Buy | 9,191 | $2.72 | $25.0K Buy | Form 4 ↗ |
| Jan 10, 2025 | Martin Brenner See Remarks, Director | IBIO iBio, Inc. | Buy | 9,191 | $2.72 | $25.0K Buy | Form 4 ↗ |
| Jan 10, 2025 | Marc Banjak Chief Legal Officer | IBIO iBio, Inc. | Buy | 9,191 | $2.72 | $25.0K Buy | Form 4 ↗ |
| Jan 10, 2025 | David Arkowitz Director | IBIO iBio, Inc. | Buy | 18,382 | $2.72 | $50.0K Buy | Form 4 ↗ |
| Jan 10, 2025 | William D. Clark Director | IBIO iBio, Inc. | Buy | 1,838 | $2.72 | $4,999 Buy | Form 4 ↗ |
| Jan 10, 2025 | Antonio Bernardino Guimaraes Parada Director | IBIO iBio, Inc. | Buy | 183,823 | $2.72 | $500.0K Buy | Form 4 ↗ |
| Jan 10, 2025 | Gary Sender Director | IBIO iBio, Inc. | Buy | 9,191 | $2.72 | $25.0K Buy | Form 4 ↗ |
11 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 7:28 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances